Castle Biosciences (CSTL) Insider Trading & Ownership $29.81 +0.93 (+3.22%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Castle Biosciences (NASDAQ:CSTL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.32 M Get CSTL Insider Trade Alerts Want to know when executives and insiders are buying or selling Castle Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CSTL Insider Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Castle Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/15/2024Frank StokesCFOSell6,923$29.93$207,205.39 11/12/2024Derek J MaetzoldInsiderSell1,972$34.15$67,343.80 11/5/2024Tobin W JuvenalInsiderSell3,507$35.56$124,708.92 10/14/2024Derek J MaetzoldInsiderSell1,972$32.27$63,636.44 10/8/2024Derek J MaetzoldInsiderSell986$30.27$29,846.22 10/7/2024Daniel BradburyDirectorSell7,867$29.44$231,604.48 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/4/2024Derek J MaetzoldInsiderSell986$28.73$28,327.78 8/12/2024Daniel BradburyDirectorSell7,883$26.65$210,081.95 8/7/2024Frank StokesCFOSell10,000$25.70$257,000.00 8/1/2024Kristen M OelschlagerCOOSell12,989$23.06$299,526.34 7/29/2024Kristen M OelschlagerCOOSell2,793$22.06$61,613.58 6/3/2024Derek J MaetzoldInsiderSell2,368$23.40$55,411.20 5/6/2024Daniel BradburyDirectorSell23,323$24.64$574,678.72 5/6/2024Derek J MaetzoldInsiderSell2,368$24.72$58,536.96 4/23/2024Derek J MaetzoldInsiderSell421$20.11$8,466.31 4/12/2024Derek J MaetzoldInsiderSell1,947$20.35$39,621.45 4/8/2024Daniel BradburyDirectorSell2,400$20.45$49,080.00 4/4/2024Daniel BradburyDirectorSell9,152$21.45$196,310.40 4/3/2024Derek J MaetzoldInsiderSell2,368$21.70$51,385.60 3/20/2024Derek J MaetzoldInsiderSell2,295$20.27$46,519.65 3/7/2024Derek J MaetzoldInsiderSell2,372$20.77$49,266.44 3/5/2024Derek J MaetzoldInsiderSell4,131$21.41$88,444.71 3/4/2024Daniel BradburyDirectorSell23,323$20.68$482,319.64 2/7/2024Daniel BradburyDirectorSell2,074$23.20$48,116.80 1/4/2024Daniel BradburyDirectorSell18,223$20.40$371,749.20 12/28/2023Derek J MaetzoldInsiderSell3,954$22.17$87,660.18 12/26/2023Derek J MaetzoldInsiderSell5,180$21.93$113,597.40 12/22/2023Derek J MaetzoldInsiderSell5,224$21.96$114,719.04 12/20/2023Derek J MaetzoldInsiderSell5,201$21.05$109,481.05 12/18/2023Derek J MaetzoldInsiderSell5,720$20.27$115,944.40 12/12/2023Daniel BradburyDirectorSell1,200$20.01$24,012.00 12/12/2023Derek J MaetzoldInsiderSell546$20.01$10,925.46 12/8/2023Daniel BradburyDirectorSell6,875$20.09$138,118.75 12/8/2023Derek J MaetzoldInsiderSell2,322$20.10$46,672.20 12/6/2023Daniel BradburyDirectorSell200$20.02$4,004.00 12/6/2023Derek J MaetzoldInsiderSell48$20.02$960.96 12/4/2023Daniel BradburyDirectorSell4,340$20.08$87,147.20 12/4/2023Derek J MaetzoldInsiderSell1,379$20.08$27,690.32 12/1/2023Daniel BradburyDirectorSell9,545$20.05$191,377.25 12/1/2023Derek J MaetzoldInsiderSell3,235$20.06$64,894.10 50-year Wall Street legend: “Sell this tech stock NOW” (Ad)Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here.11/29/2023Daniel BradburyDirectorSell17,342$20.12$348,921.04 11/29/2023Derek J MaetzoldInsiderSell5,743$20.13$115,606.59 11/24/2023Daniel BradburyDirectorSell800$20.02$16,016.00 11/24/2023Derek J MaetzoldInsiderSell287$20.03$5,748.61 (Data available from 1/1/2013 forward) CSTL Insider Trading Activity - Frequently Asked Questions Who is on Castle Biosciences's Insider Roster? The list of insiders at Castle Biosciences includes Daniel Bradbury, Derek J Maetzold, Ellen Goldberg, Frank Stokes, Kristen M Oelschlager, Tiffany Olson, and Tobin W Juvenal. Learn more on insiders at CSTL. What percentage of Castle Biosciences stock is owned by insiders? 7.20% of Castle Biosciences stock is owned by insiders. Learn more on CSTL's insider holdings. Which Castle Biosciences insiders have been buying company stock? The following insiders have purchased CSTL shares in the last 24 months: Ellen Goldberg ($69,024.00), and Tiffany Olson ($24,983.00). How much insider buying is happening at Castle Biosciences? Insiders have purchased a total of 5,962 CSTL shares in the last 24 months for a total of $94,007.00 bought. Which Castle Biosciences insiders have been selling company stock? The following insiders have sold CSTL shares in the last 24 months: Daniel Bradbury ($5,446,373.60), Derek J Maetzold ($2,132,763.19), Frank Stokes ($464,205.39), Kristen M Oelschlager ($361,139.92), and Tobin W Juvenal ($124,708.92). How much insider selling is happening at Castle Biosciences? Insiders have sold a total of 383,052 Castle Biosciences shares in the last 24 months for a total of $8,529,191.02 sold. Castle Biosciences Key ExecutivesMr. Derek J. Maetzold (Age 62)Founder, CEO, President & Director Compensation: $1.45M5 recent tradesMr. Frank Stokes (Age 53)CFO & Treasurer Compensation: $849.36k2 recent tradesMs. Kristen M. Oelschlager R.N. (Age 56)Chief Operating Officer Compensation: $782.7k2 recent tradesMr. Tobin W. Juvenal (Age 64)Chief Commercial Officer Compensation: $782.7k1 recent tradesCamilla ZuckeroVice President of Investor Relations & Corporate AffairsMs. Alice Bahner IzzoSenior Vice President of MarketingMr. Kevin DomanVice President of SalesMs. Keli GreenbergVP of Human Resources & Executive Director of Human ResourcesDr. Robert W. Cook Ph.D. (Age 52)Senior Vice President of Research & Development Dr. Matthew Goldberg M.D.Senior Vice President of Medical More Insider Trading Tools from MarketBeat Related Companies MYGN Insider Transactions VCYT Insider Transactions SGRY Insider Transactions LFST Insider Transactions PACS Insider Transactions PRVA Insider Transactions ADUS Insider Transactions WGS Insider Transactions NHC Insider Transactions TDOC Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CSTL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
